迪卡斯(DCTH)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

DCTH 迪卡斯

盘前交易 10-05 04:44:36 EDT

15.13

-0.28

-1.82%

盘前15.03

-0.10-0.66%

04:00 EDT

最高15.60	最低15.06	成交量43.66万
今开15.57	昨收15.41	日振幅3.50%
总市值5.25亿	流通市值4.33亿	总股本3,470万
成交额664.00万	换手率1.53%	流通股本2,859万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"DCTH","market":"US","secType":"STK","nameCN":"迪卡斯","latestPrice":15.13,"timestamp":1790971200000,"preClose":15.41,"halted":0,"volume":436636,"hourTrading":{"tag":"盘前","latestPrice":15.03,"preClose":15.13,"latestTime":"04:00 EDT","volume":1,"amount":15.03,"timestamp":1791187202446,"change":-0.1,"changeRate":-0.006609,"amplitude":0},"delay":0,"changeRate":-0.01817001946787796,"floatShares":28593060,"shares":34698795,"eps":0.0147,"marketStatus":"盘前交易","change":-0.28,"latestTime":"10-05 04:44:36 EDT","open":15.57,"high":15.6,"low":15.06,"amount":6639964.259148,"amplitude":0.035042,"askPrice":18.25,"askSize":100,"bidPrice":11.89,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.0147,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791207000000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":15.13,"preHourTrading":{"tag":"盘前","latestPrice":15.03,"preClose":15.13,"latestTime":"04:00 EDT","volume":1,"amount":15.03,"timestamp":1791187202446,"change":-0.1,"changeRate":-0.006609,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":15.13,"preClose":15.13,"latestTime":"19:30 EDT","volume":4901,"amount":74152.13,"timestamp":1790983804285,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.3652213062387877,"impliedVol":0.7154,"impliedVolPercentile":0.428},"requestUrl":"/m/hq/s/DCTH/wiki","defaultTab":"wiki","newsList":[{"id":"1162529063","title":"迪卡斯宣布首例肝转移性乳腺癌患者接受Hepzato™二期临床试验给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1162529063","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1162529063?lang=zh_cn&edition=full","pubTime":"2026-07-09 20:02","pubTimestamp":1783598544,"startTime":"0","endTime":"0","summary":"迪卡斯（Delcath Systems）宣布，其用于治疗肝脏主导型转移性乳腺癌的药物Hepzato™，已在二期临床试验中为首位患者完成给药。这一进展标志着该创新疗法的临床开发迈出了关键一步。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DCTH","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135511347","title":"迪卡斯系统公司宣布Chemosat美法仑肝脏给药系统被纳入ESMO-EURACAN葡萄膜黑色素瘤临床实践指南推荐治疗方案","url":"https://stock-news.laohu8.com/highlight/detail?id=1135511347","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1135511347?lang=zh_cn&edition=full","pubTime":"2026-04-06 20:32","pubTimestamp":1775478747,"startTime":"0","endTime":"0","summary":"迪卡斯系统公司（Delcath Systems, Inc.）近日宣布，其Chemosat美法仑肝脏给药系统已被正式纳入ESMO-EURACAN葡萄膜黑色素瘤临床实践指南，成为肝脏导向区域治疗的推荐选择方案。这一重要认可标志着该创新疗法在专业医疗指南中的地位获得权威确认。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DCTH","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518227182","title":"迪卡斯盘中异动 股价大跌7.68%报12.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518227182","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518227182?lang=zh_cn&edition=full","pubTime":"2025-03-10 22:00","pubTimestamp":1741615239,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日22时00分，迪卡斯股票出现波动，股价急速下跌7.68%。截至发稿，该股报12.00美元/股，成交量14.4332万股，换手率0.43%，振幅4.77%。最近的财报数据显示，该股实现营业收入37.21百万美元，净利润-26.39百万美元，每股收益-0.93美元，毛利31.02百万美元，市盈率-13.32倍。机构评级方面，在所有7家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。迪卡斯股票所在的医疗器械行业中，整体跌幅为1.18%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220039a26a2fe2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310220039a26a2fe2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DCTH","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518726284","title":"迪卡斯2024财年实现净利润-26.39百万美元，同比增加44.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518726284","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518726284?lang=zh_cn&edition=full","pubTime":"2025-03-10 00:01","pubTimestamp":1741536073,"startTime":"0","endTime":"0","summary":"3月10日，迪卡斯公布财报，公告显示公司2024财年净利润为-26.39百万美元，同比增加44.65%；其中营业收入为37.21百万美元，同比增加1697.58%，每股基本收益为-0.93美元。从资产负债表来看，迪卡斯总负债7.84百万美元，其中短期债务105000.00美元，资产负债比为9.77，流动比率为12.02。机构评级：截至2025年3月10日，当前有7家机构对迪卡斯目标价做出预测，其中目标均价为22.43美元，其中最低目标价为21.00美元，最高目标价为25.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000219abf1755e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310000219abf1755e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DCTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171927339","title":"Delcath Systems 2024年第四季度GAAP每股收益$(0.11)，低于$(0.02)预期；销售额$15.10百万，超出$13.78百万预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1171927339","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1171927339?lang=zh_cn&edition=full","pubTime":"2025-03-06 21:07","pubTimestamp":1741266431,"startTime":"0","endTime":"0","summary":"Delcath Systems报告其季度每股亏损为$，较分析师共识预期的$低450%。公司报告季度销售额为$15.10百万，超出分析师共识预期的$13.78百万，增长了9.58%。与去年同期的$539.00千相比，销售额增长了2.70K%。以上内容来自Benzinga Earnings专栏，原文如下：Delcath Systems  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 450 percent. This is a 77.08 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $15.10 million which beat the analyst consensus estimate of $13.78 million by 9.58 percent.  ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Delcath Systems 2024年第四季度GAAP每股收益$(0.11)，低于$(0.02)预期；销售额$15.10百万，超出$13.78百万预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DCTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516087866","title":"迪卡斯盘中异动 早盘大幅下跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516087866","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516087866?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:08","pubTimestamp":1741100902,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时08分，迪卡斯股票出现异动，股价快速跳水5.17%。截至发稿，该股报12.66美元/股，成交量6.6373万股，换手率0.18%，振幅3.37%。机构评级方面，在所有7家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。迪卡斯股票所在的医疗器械行业中，整体跌幅为0.58%。迪卡斯公司简介：Delcath Systems Inc是一家肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304230822abe7faed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304230822abe7faed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","DCTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516681126","title":"迪卡斯盘中异动 股价大跌5.08%报13.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516681126","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516681126?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:10","pubTimestamp":1741032653,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时10分，迪卡斯股票出现波动，股价快速下挫5.08%。截至发稿，该股报13.45美元/股，成交量19.3988万股，换手率0.54%，振幅6.15%。最近的财报数据显示，该股实现营业收入11.20百万美元，净利润1.86百万美元，每股收益0.06美元，毛利9.56百万美元，市盈率-11.54倍。机构评级方面，在所有7家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。迪卡斯股票所在的医疗器械行业中，整体涨幅为0.67%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304041053989a5b2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304041053989a5b2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DCTH","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514358133","title":"迪卡斯盘中异动 急速下跌5.05%报13.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514358133","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514358133?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:55","pubTimestamp":1740689758,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时55分，迪卡斯股票出现波动，股价急速下挫5.05%。截至发稿，该股报13.92美元/股，成交量28.222万股，换手率0.78%，振幅4.57%。机构评级方面，在所有7家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。迪卡斯股票所在的医疗器械行业中，整体跌幅为0.74%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280455589632f674&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280455589632f674&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DCTH","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514863302","title":"迪卡斯盘中异动 股价大涨5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514863302","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514863302?lang=zh_cn&edition=full","pubTime":"2025-02-27 01:18","pubTimestamp":1740590319,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日01时18分，迪卡斯股票出现异动，股价快速上涨5.05%。截至发稿，该股报14.97美元/股，成交量5.8328万股，换手率0.16%，振幅4.91%。机构评级方面，在所有7家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。迪卡斯股票所在的医疗器械行业中，整体涨幅为0.98%。迪卡斯公司简介：Delcath Systems Inc是一家肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227011840abde11ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227011840abde11ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","DCTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514086277","title":"迪卡斯盘中异动 下午盘股价大跌5.04%报14.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514086277","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514086277?lang=zh_cn&edition=full","pubTime":"2025-02-25 03:54","pubTimestamp":1740426872,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日03时54分，迪卡斯股票出现波动，股价大幅下跌5.04%。截至发稿，该股报14.13美元/股，成交量35.5748万股，换手率0.98%，振幅5.71%。机构评级方面，在所有7家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。迪卡斯股票所在的医疗器械行业中，整体涨幅为0.64%。迪卡斯公司简介：Delcath Systems Inc是一家肿瘤学公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225035433a252580c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225035433a252580c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DCTH","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2504118845","title":"Craig-Hallum：维持Delcath Systems评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2504118845","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504118845?lang=zh_cn&edition=full","pubTime":"2025-01-18 02:14","pubTimestamp":1737137652,"startTime":"0","endTime":"0","summary":"Craig-Hallum：维持Delcath Systems(DCTH.US)评级，由买入调整至买入评级,目标价由18.00美元调整至21.00美元。迪卡斯(DCTH.US)公司简介：Delcath Systems Inc是一家肿瘤学公司。它专注于原发性和转移性肝癌的治疗。该公司的产品Melphalan Hydrochloride for Injection与Delcath Hepatic Delivery System(或称Melphalan/HDS)是一种药物和设备的组合产品，旨在向肝脏输送高剂量的化疗药物，同时控制全身暴露和相关的副作用。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118022502a225ef5a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250118022502a225ef5a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["DCTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154934630","title":"这9只生物科技股今年已暴涨翻倍，分析师预测未来还有翻倍空间！","url":"https://stock-news.laohu8.com/highlight/detail?id=1154934630","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1154934630?lang=zh_cn&edition=full","pubTime":"2024-10-17 13:46","pubTimestamp":1729143997,"startTime":"0","endTime":"0","summary":"9只医疗保健股票今年股价已经翻倍，根据分析师的预测，这9只股票未来仍有超过100%的上涨潜力。生物科技行业的股票通常被分析师视为比其他行业的投资风险更高。根据五位分析师的目标价中值，预计 Benitec 未来 12 个月将上涨 104%。Praxis今年迄今已上涨223%，跟踪该股票的10位分析师预计未来12个月将上涨103%。Humacyte今年已翻倍，分析师预计它在未来12个月内还将再次翻倍。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/ae91103f9636ad1491772cb329b87218","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/ae91103f9636ad1491772cb329b87218"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"这9只生物科技股今年已暴涨翻倍，分析师预测未来还有翻倍空间！","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HUMA","ARQT","JSPR","RZLT","CRBP","BNTC","PRAX","TRVI","DCTH"],"isVideo":false,"video":null,"gpt_icon":1}],"profile":{"websiteUrl":"http://www.delcath.com","stockEarnings":[{"period":"1week","weight":-0.0301},{"period":"1month","weight":-0.0875},{"period":"3month","weight":0.1462},{"period":"6month","weight":0.5711},{"period":"1year","weight":0.4207},{"period":"ytd","weight":0.498}],"compareEarnings":[{"period":"1week","weight":-0.0022},{"period":"1month","weight":0.0059},{"period":"3month","weight":0.0334},{"period":"6month","weight":0.1735},{"period":"1year","weight":0.1501},{"period":"ytd","weight":0.1286}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Delcath Systems, Inc.于1988年8月在特拉华州公司注册成立。该公司是一家介入肿瘤学公司，专注于原发性和肝脏转移性癌症的治疗。该公司的主导产品HEPZATOTM KIT（“HEPZATO”melphalan for Injection/ liver Delivery System）是一种药物/设备组合产品，于2023年8月14日获得美国食品和药物管理局（FDA）的批准，用于治疗伴有不可切除肝转移的葡萄膜黑色素瘤成年患者，该患者的肝脏转移影响不到50%的肝脏，无肝外疾病，或肝外疾病局限于骨骼、淋巴结、皮下组织。","yearOnYearQuotes":[{"month":1,"riseRate":0.56,"avgChangeRate":0.024993},{"month":2,"riseRate":0.36,"avgChangeRate":-0.071948},{"month":3,"riseRate":0.44,"avgChangeRate":-0.035888},{"month":4,"riseRate":0.36,"avgChangeRate":0.230646},{"month":5,"riseRate":0.44,"avgChangeRate":-0.043357},{"month":6,"riseRate":0.4,"avgChangeRate":3.378958},{"month":7,"riseRate":0.4,"avgChangeRate":-0.080184},{"month":8,"riseRate":0.56,"avgChangeRate":0.030301},{"month":9,"riseRate":0.28,"avgChangeRate":-0.067683},{"month":10,"riseRate":0.32,"avgChangeRate":-0.065474},{"month":11,"riseRate":0.28,"avgChangeRate":-0.083536},{"month":12,"riseRate":0.6,"avgChangeRate":0.060901}],"exchange":"NASDAQ","name":"迪卡斯","nameEN":"DELCATH SYSTEMS INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"迪卡斯(DCTH)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供迪卡斯(DCTH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"迪卡斯,DCTH,迪卡斯股票,迪卡斯股票老虎,迪卡斯股票老虎国际,迪卡斯行情,迪卡斯股票行情,迪卡斯股价,迪卡斯股市,迪卡斯股票价格,迪卡斯股票交易,迪卡斯股票购买,迪卡斯股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"迪卡斯(DCTH)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供迪卡斯(DCTH)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}